Lineage Cell Therapeutics In shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $792k | 727k | 1.09 |
| 2023-09-30 | $837k | 710k | 1.18 |
| 2023-06-30 | $1.5M | 1.0M | 1.41 |
| 2023-03-31 | $0 | 1.1M | 0.00 |
| 2022-12-31 | $1.3M | 1.1M | 1.17 |
| 2022-06-30 | $2.0M | 1.3M | 1.58 |
| 2022-03-31 | $2.8M | 1.8M | 1.51 |
| 2021-12-31 | $3.1M | 1.3M | 2.45 |
| 2021-03-31 | $0 | 73 | 0.00 |
| 2020-12-31 | $4.1k | 2.3k | 1.83 |
| 2020-09-30 | $12k | 13k | 0.96 |
| 2020-06-30 | $5.1k | 5.5k | 0.92 |
| 2020-03-31 | $148k | 179k | 0.83 |
| 2019-12-31 | $126k | 142k | 0.89 |
| 2019-09-30 | $35k | 36k | 0.99 |